HR
CMD

Hardy Reed’s Cantel Medical Corporation CMD Stock Holding History

Hardy Reed’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,757
Closed -$206K – 74
2019
Q3 		$206K Hold
2,757
– – 0.08% 63
2019
Q2 		$222K Buy
+2,757
New +$194K 0.09% 60

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Hardy Reed's CMD Position: Q4 2019 in Review

Hardy Reed sold out of Cantel Medical Corporation (CMD) in Q4 2019, closing a stake of 2,757 shares — an estimated $206K sold.

Hardy Reed first reported a position in CMD in Q2 2019 and held it in 2 quarters. The position peaked at $222K in Q2 2019. 237 funds tracked by Wall St. Rank hold CMD as of Q4 2019.

  • Hardy Reed reported no remaining Cantel Medical Corporation position as of Q4 2019 after selling out during the quarter.
  • Hardy Reed sold 2,757 Cantel Medical Corporation shares in Q4 2019, an estimated $206K.
  • Hardy Reed first reported a position in Cantel Medical Corporation in Q2 2019 and held it in 2 quarters.
  • Hardy Reed's Cantel Medical Corporation position peaked at $222K in Q2 2019.
  • 237 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2019.

Based on Hardy Reed's 13F filing for Q4 2019, filed 24 Jan 2020.